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Phospholipase D1 localises to secretory granules and lysosomes
and is plasma-membrane translocated on cellular stimulation
Fraser D. Brown*, Nicola Thompson†, Khalid M. Saqib*, Joanna M. Clark*, 
Dale Powner*, Neil T. Thompson†, Roberto Solari† and Michael J.O. Wakelam*
Phospholipase D (PLD) activity has been implicated in
the regulation of membrane trafficking [1,2], superoxide
generation and cytoskeletal remodelling [3,4]. Several
PLD genes have now been identified and it is probable
that different isoforms regulate distinct functions.
Defining the subcellular localisation of each isoform
would facilitate understanding of their roles. Previous
PLD localisation studies have been based largely on
enzyme activity measurements, which cannot
distinguish between isoforms [2,5]. We have cloned the
cDNAs encoding human PLD1a and PLD1b from an
HL60 cell cDNA library and expressed them as
catalytically active fusion proteins with green
fluorescent protein (GFP) in COS-1 cells and RBL-2H3
cells, a mast cell model which degranulates upon cross-
linking of the high-affinity immunoglobulin E (IgE)
receptor. In unstimulated cells, GFP–PLD1b colocalised
with secretory granule and lysosomal markers; it was
not found at the plasma membrane or nucleus and did
not colocalise with markers for the Golgi. Stimulation
of RBL-2H3 cells through IgE receptor cross-linking
caused plasma membrane recruitment of GFP–PLD1b.
Inhibition of IgE-receptor-stimulated, PLD-catalysed
phosphatidate formation suppressed secretion of
granule and lysosomal contents, but did not affect
translocation of GFP–PLD1b. These experiments
suggest that PLD1 plays a role in regulated exocytosis
rather than endoplasmic reticulum (ER) to Golgi
membrane transport. 
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Results and discussion
The cDNAs encoding PLD1a and PLD1b were isolated
from an HL60 cell cDNA library and cloned into the
pCMV–neo–HA (provided by Onyx Pharmaceuticals) and
pEGFP-C1 (Clontech) vectors. The PLD sequences were
identical to those reported previously [6] except for a
three amino acid insertion (EAV, in the single-letter
amino-acid code) at position 1026. Expression of hemag-
glutinin (HA)-tagged and GFP-tagged PLD1b in COS-1
cells generated an ADP ribsolylation factor (ARF)-sensi-
tive, phosphatidylinositol 4,5-bisphosphate (PIP2)-depen-
dent PLD activity (Figure 1a), which was stimulated by
the inclusion of the Rho GTPase family member Rac
(data not shown). Expression plasmids containing PLD1a
generated similar PLD activities (data not shown). 
To confirm that the tagged versions of PLD behaved
identically in terms of intracellular localisation, COS-1
cells were co-transfected with both HA–PLD1b and
GFP–PLD1b. Considerable overlap of the fusion proteins
was observed (Figure 1b); distribution of tagged PLD1b
was usually punctate but, occasionally, a more diffuse dis-
tribution including some perinuclear staining was seen.
Essentially no overlap of GFP–PLD1b expression was
detected with an antibody (HFD9; [7]) directed against a
cis Golgi protein (Figure 1c). 
PLD1b expression has been detected in RBL-2H3 cells
by northern blot hybridisation analysis (P.J. Parker, per-
sonal communication) and it is likely that this isoform is
responsible for some of the IgE-receptor-stimulated activ-
ity [8]. In transfected RBL-2H3 cells, both GFP–PLD1b
and HA–PLD1b displayed a punctate distribution with no
plasma membrane or nuclear localisation. From published
studies, a possible location for PLD would be the Golgi
[2]. However, neither TGN 38 (Figure 2a), a marker for an
integral membrane protein predominately found in the
trans-Golgi network, nor mannosidase II (Figure 2b),
which is expressed in the medial compartment of the
Golgi stack, colocalised with GFP–PLD1b. HA–PLD also
did not colocalise with TGN 38 in RBL-2H3 cells (Figure
2c). The Golgi markers displayed peri-nuclear staining
identical to that in non-transfected cells, demonstrating
that transfection had not disrupted Golgi structure. 
There is evidence of a role for PLD in regulated exocytosis
[9]. Therefore, PLD localisation was determined in compar-
ison with secretory granule and lysosomal markers
(Figure 3). GFP–PLD1b fluorescence (Figure 3a) and stain-
ing for 5-hydroxytryptamine (5HT; Figure 3b), a marker of
secretory granules, clearly overlapped (Figure 3c). Similarly,
GFP–PLD1b fluorescence (Figure 3d) and staining for
Lgp120 (Figure 3e), a glycoprotein found in lysosomes,
demonstrated considerable colocalisation (Figure 3f). The
Lys860→Glu (K860E) mutation of PLD1b was also gener-
ated and found to be catalytically inactive when expressed
in COS-1 cells (data not shown). GFP–PLD1b-K860E also
colocalised with 5HT (Figure 4e), demonstrating that asso-
ciation was not a consequence of the elevated PLD activity
induced by the GFP-tagging of PLD1b.
In unstimulated cells, no plasma membrane fluorescence
was observed (Figure 4a). Stimulation of RBL-2H3 cells
through IgE receptor ligation (Figure 4b,c), or with
phorbol 12-myristate 13-acetate (PMA; 100 nM) for
20 minutes (data not shown) induced the translocation of
GFP–PLD1b to the plasma membrane. Partial transloca-
tion could be observed within 1 minute. Figure 4b shows a
cell in which only a proportion of the secretory vesicles
had translocated to the plasma membrane following a
3 minute stimulation. Not all of the GFP–PLD1b translo-
cated to the plasma membrane, indeed in some cells con-
siderable punctate GFP–PLD1b fluorescence remained
observable after 40 minutes, the longest time point exam-
ined. To determine if the phosphatidic acid derived from
stimulated PLD activity was required for translocation, its
formation was inhibited by incubating cells with 0.3%
butan-1-ol before IgE receptor ligation. No difference was
observed in the stimulated relocation of GFP–PLD1
between the control and alcohol-treated cells (Figure 4d).
An identical pattern of staining was detected with
GFP–PLD1a (data not shown).
Cross-linking of the IgE receptor on RBL-2H3 cells
induces the release of secretory granule and lysosomal
contents. A critical role for PLD in this process was
demonstrated by a greater inhibition of degranulation
when the cells were stimulated in the presence of butan-
1-ol than butan-2-ol (Figure 4f). Primary alcohol (0.1%)
inhibited the release of about 45% of 5HT and about 35%
of hexosaminidase; 0.1% butan-2-ol was without effect.
Butan-1-ol (0.3%) inhibited hexosaminidase and 5HT
release by 70% but the same butan-2-ol concentration
836 Current Biology, Vol 8 No 14
Figure 1
Expression of PLD1b in COS-1 cells.
(a) Activity of GFP–PLD1b expressed in
COS-1 cells is PIP2-dependent and ARF-
dependent. (b,c) GFP–PLD1b (green) co-
localised with HA–PLD1b (red, panel b), but
not with HFD9 antibody staining (red, panel c).
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Figure 2
PLD1b is not localised to the Golgi in RBL-2H3 cells. Localisation of (a)
GFP–PLD1b (green) and TGN 38 (red); (b) GFP–PLD1b (green) and
mannosidase II (red); and (c) HA–PLD1b (green) and TGN 38 (red). 
Figure 3
PLD1b is localised to secretory granules and lysosomes.
(a,d) GFP–PLD1b co-localised with antibodies against (b) a granule
marker, 5HT, and (e) a lysosomal marker, Lgp120. (c,f) Composite
images showing GFP–PLD1b in green and antibody staining in red. 
only inhibited degranulation by 30%. The dose depen-
dency of stimulated phosphatidylbutanol formation in
these cells correlated with the ability of the alcohol to
block secretion, both being maximal at 0.1% butan-1-ol
(data not shown and Figure 4f). No phosphatidylbutan-2-
ol was formed, suggesting that the inhibitory effects of
butan-2-ol were non-specific. In contrast to receptor cross-
linking, PMA did not stimulate the release of hex-
osaminidase (data not shown). Thus, whilst PLD
activation is necessary for secretion, its plasma membrane
recruitment and stimulation by protein kinase C (PKC)
represent only two components of a complete secretory
response. There are multiple steps in the exocytotic
pathway and PMA clearly does not activate them all. For
instance, an increase in intracellular Ca2+ concentration is
not generated by PMA and thus Ca2+-dependent proteins
involved in secretion will not be activated. 
The results presented in this paper clearly demonstrate
that, in the RBL-2H3 cell line, PLD1 is present on the
secretory granules and lysosomes and not, as might have
been expected from published studies, on the Golgi
[4,10,11], ER [1] or nucleus [2,5]. Secretory granules of cells
in the haematopoietic lineage are ‘secretory lysosomes’ [12],
which contain lysosomal hydrolases and secretory proteins. 
Substantial biochemical evidence exists to support a role
for a PLD activity in the formation of coated vesicles
during membrane transport through the secretory pathway
[12]. Subcellular localisation studies have not, however,
unequivocally demonstrated PLD in the corresponding
organelles. The overexpression of an HA-epitope-tagged
PLD1 in serum-starved REF-52 fibroblasts resulted in a
staining pattern consistent with the Golgi, ER and late
endosomes, but the lack of colocalisation data using
markers to these or other subcellular compartments left
the exact location of PLD1 undetermined [4]. Other local-
isation studies have been based on subcellular fractiona-
tion and subsequent assay of PLD activity, which does not
distinguish between isoforms. These were largely unable
to detect any PLD activity in fractions corresponding to
granules and lysosomes.
Recently, a PLD activity was detected associated with
neutrophil vesicles that can, following stimulation, be
found at the plasma membrane [13]; our results suggest
that this activity may be composed of PLD1b and/or
PLD1a. We found no evidence for localisation of PLD1a
or PLD1b to the Golgi or ER, and therefore must ques-
tion the role of these particular isoforms in ER to Golgi
transport events. Nevertheless, the biochemical evidence
for a PLD activity in this process is strong [1]. PLD2,
because of its constitutively active state, is a potential can-
didate for this function, although recent data suggest that
it is localised to the plasma membrane [4]. Thus, the PLD
isoforms involved in other vesicle transport steps remain
to be identified. It is possible that the localisation of PLD
isoforms is cell specific or that additional PLD isoforms
remain to be identified. 
The data presented in this paper support a model whereby
PLD1, present on secretory granules and lysosomes, is
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Figure 4
GFP–PLD1b localises to the plasma
membrane in stimulated RBL-2H3 cells, and
PLD activity is required for secretion of
granule and lysosomal contents. (a) No
plasma membrane staining was observed in
untreated cells. (b) Cross-linking of the high-
affinity IgE receptor caused partial plasma
membrane translocation of GFP–PLD1b after
3 min and (c) increased translocation after
20 min. (d) The inclusion of 0.3% butan-1-ol
had no effect on stimulated re-localisation.
(e) GFP–PLD1b-K860E (green) colocalised
with 5HT (red) in RBL-2H3 cells. (f) Secretion
of hexosaminidase (grey bars) and 5HT (white
bars), stimulated by cross-linking of the high-
affinity IgE receptor, was inhibited to a greater
extent by butan-1-ol than butan-2-ol.
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recruited to the plasma membrane in response to antigen
stimulation. During this process, PLD is activated and
generates phosphatidic acid, which fulfils an essential role
in the secretion of the contents of the vesicles with which
PLD1 colocalises. We do not rule out the possibility that
the conversion of phosphatidic acid to diacylglycerol is
necessary for secretion as reported in yeast [14]. There is,
however, increasing evidence to indicate that phosphatidic
acid is the signal generated by PLD [15].
Materials and methods
Culture and transfection of cells
COS-1 and RBL-2H3 cells were transfected by electroporation and
allowed to adhere to coverslips or dishes overnight in fresh medium.
Anti-DNP IgE (1 µg/ml) was included for at least 1 h prior to PBS
washing and stimulation with 1 µg/ml KLH-DNP (Calbiochem). Identi-
cal data were obtained when cells were examined 48 h post-transfec-
tion. For secretory experiments, cells were incubated overnight with
1 µCi/ml [3H]5HT.
Confocal microscopy 
Golgi membranes were stained with monoclonal antibodies against
TGN 38, mannosidase II (both kindly provided by G. Banting) or with
HFD9 monoclonal antibody (kindly provided by V.N. Subramaniam) [7].
Endosomes were stained with a monoclonal antibody to the transferrin
receptor (kindly provided by C. Hopkins). Lysosomes were visualised
with a monoclonal antibody against the lysosomal glycoprotein Lgp120
(kindly provided by I. Mellman) and secretory granules visualised using
a monoclonal antibody to 5HT (Biogenesis).
Analysis of regulated secretion
Secretion from RBL-2H3 cells was quantified by determining the
release of hexosaminidase enzymatically using p-nitrophenyl-N-acetyl-D-
glucosamine as a substrate and the release of [3H]5HT, measured by
scintillation counting. 
Determination of PLD activity
Transfected COS-1 cells were lysed and PLD activity determined using
a [3H]phosphatidylcholine-containing substrate micelle with [3H]choline
generation determined as described [16].
Acknowledgements
This work was funded by the Wellcome Trust. F.D.B. is an MRC/Glaxo-
Wellcome collaborative student. J.M.C. is a BBSRC-funded student. We
thank Matthew Hodgkin for criticism of the manuscript. F.D.B. thanks Martin
Sims for his expert instruction in molecular biology. 
References
1. Bi K, Roth MG, Ktistakis NT: Phosphatidic acid formation by
phospholipase D is required for transport from the endoplasmic
reticulum to the Golgi complex. Curr Biol 1997, 7:301-307.
2. Ktistakis NT, Brown HA, Sternweis PC, Roth MG: Phospholipase D
is present on Golgi-enriched membranes and its activation by
ADP ribosylation factor is sensitive to brefeldin A. Proc Natl Acad
Sci USA 1995, 92:4952-4956.
3. Cross MJ, Roberts S, Ridley AJ, Hodgkin MN, Stewart A, Claesson-
Welsh L, Wakelam MJO: Stimulation of actin stress fibre formation
mediated by activation of phospholipase D. Curr Biol 1996, 
6:588-597.
4. Colley WC, Sung T-C, Roll R, Jenco J, Hammond SM, Altshuller Y, et
al.: Phospholipase D2, a distinct phospholipase D isoform with
novel regulatory properties that provokes cytoskeletal
reorganisation. Curr Biol 1997, 7:191-201.
5. Balboa MA, Insel PA: Nuclear phospholipase D in Madin-Darby
canine kidney cells. Guanosine 5¢-O-(thiotriphosphate)-
stimulated activation is mediated by RhoA and is downstream of
protein-kinase-C. J Biol Chem 1995, 270:29843-29847.
6. Hammond SM, Jenco J, Nakashima S, Cadwallader K, Gu QM, Cook
S, et al.: Characterisation of two alternatively spliced forms of
phospholipase D1. Activation of the purified enzymes by
phosphatidylinositol 4,5-bisphosphate, ADP-ribosylation factor,
and Rho family monomeric GTP-binding proteins and protein
kinase C-alpha. J Biol Chem 1997, 272:3860-3868.
7. Subramaniam VN, Krijnse-Locker J, Tang BL, Ericsson M, Yusoff ARM,
Griffiths G, Hong W: Monoclonal antibody HFD9 identifies a novel
28kDa integral membrane protein on the cis-Golgi. J Cell Sci
1995, 108:2405-2414.
8. Lin PY, Gilfillan AM: The role of calcium and protein kinase C in the
IgE-dependent activation of phosphatidylcholine-specific
phosholipase D in a rat mast (RBL 2H3) cell line. Eur J Biochem
1992, 207:163-168.
9. Fensome A, Cunningham E, Prosser S, Tan SK, Swigart P, Thomas G,
et al.: ARF and PITP restore GTPgS-stimulated protein secretion
from cytosol-depleted HL60 cells by promoting PIP2 synthesis.
Curr Biol 1996, 6:730-738.
10. Chen YG, Siddhanta Y, Austin CD, Hammond SM, Sung T-C,
Frohman MA, et al.: Phospholipase D stimulates release of
nascent secretory vesicles from the trans-Golgi network. J Cell
Biol 1997, 138:495-504.
11. Ktistakis NT, Brown HA, Waters MG, Sternweis PC, Roth MG:
Evidence that phospholipase-D mediates ADP-ribosylation factor-
dependent formation of Golgi coated vesicles. J Cell Biol 1996,
134:295-306.
12. Griffiths GM: Secretory lysosomes - a special mechanism of
regulated secretion in haemopoietic cells. Trends Cell Biol 1996,
6:329-332.
13. Morgan CP, Sengelov H, Whatmore J, Borregaard N, Cockcroft S:
ADP-ribosylation factor-regulated phospholipase D activity
localizes to secretory vesicles and mobilises to the plasma
membrane following N-methionyl-formyl-leucyl-phenylalanine
stimulation of human neutrophils. Biochem J 1997, 325:581-585.
14. Kearns BG, McGee TP, Mayinger P, Gedvilaite A, Phillips SE,
Kagiwada S, Bankaitis VA: Essential role for diacylglycerol in
protein transport from the yeast Golgi complex. Nature 1997,
387:101-105.
15. Pettitt TR, Martin A, Horton T, Liossis C, Lord JM, Wakelam MJO:
Diacylglycerol and phosphatidate generated by phospholipases C
and D, respectively, have distinct fatty acid compositions and
functions: phospholipase D-derived diacylglycerol does not
activate protein kinase C in PAE cells. J Biol Chem 1997,
272:17354-17359.
16. Martin A, Brown FD, Hodgkin MN, Bradwell AJ, Cook SJ, Hart M,
Wakelam MJO: Activation of phospholipase D and
phosphatidylinositol 4-phosphate 5-kinase in HL60 membranes is
mediated by endogenous Arf but not Rho. J Biol Chem 1996,
271:17397-17403.
838 Current Biology, Vol 8 No 14
